HR 7871
MVP Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 1:53 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Medicaid VBPs for Patients Act (MVP Act) aims to modernize how Medicaid pays for drugs by allowing states to use ‘value-based purchasing arrangements.’ These arrangements link drug prices to patient outcomes, particularly for expensive new treatments like gene therapies. The bill updates regulations to accommodate multiple price points from manufacturers and clarifies how these arrangements affect Medicare payments, while also directing the GAO to study the impact of these arrangements on healthcare costs and patient access.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.